Company profile
DermTech company profile
DermTech develops and commercializes qPCR assays for skin samples collected non-invasively using adhesive tape biopsy methods. The Company’s assays can analyze multiple gene targets to assess their level of RNA expression. The Company anticipates providing these assays through a CLIA certified laboratory located in San Diego. The Company will initially offer an assay for pigmented skin lesions sampled using an adhesive tape collection method. The Company has identified gene targets differentially expressed in melanoma samples (British Journal of Dermatology, April 2011). This assay can assess RNA expression consistent with melanoma with very high sensitivity (>95%) and specificity (>70%).
Business identity
- Website
- http://dermtech.com
- Contact email
- [email protected]
- Phone number
- +1 858 450 4222
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $1M-$10M
- Founded
- 1996-01-01, Year
Headquarters
- Headquarters
- San Diego, California, United States
- Postal code
- 92037
- Country code
- US
- Continent
- North America